Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus

Lerbæk, Anne; Agner, Tove

doi:10.1111/j.1365-2133.2004.06008.x

Cited by 24 publications

(16 citation statements)

References 3 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…MC have been described during treatment with topical tacrolimus for AD or vitiligo [20,21]. However, in our series, despite the large number of children studied, only 1 case of MC occurred after treatment with topical tacrolimus.…”

Section: Discussioncontrasting

confidence: 44%

Clinical Characteristics of Molluscum Contagiosum in Children in a Private Dermatology Practice in the Greater Paris Area, France: A Prospective Study in 661 Patients

Osio¹,

Deslandes

Saada³

et al. 2011

Dermatology

View full text Add to dashboard Cite

Background: Series regarding the clinical characteristics of molluscum contagiosum (MC) are retrospective and concern small defined populations seen in a hospital setting. Methods: We prospectively studied patients under 15 years of age with MC seen in 25 private dermatology practices in the greater Paris area during 1 year. Results: Six hundred fifty patients were included. The mean age was 6 years. Of the patients, 30.5% had had MC in the past, 53% had 5–20 MC, 43% had a history of atopic dermatitis (AD), 5% were using topical steroids, 25.5% had coexistent AD, 13% had giant MC (>5 mm), 21% had inflammatory MC, and 19% had MC surrounded by eczema. Bathing with siblings was associated with a higher number of MC. A history of AD was associated with the presence of MC surrounded by eczema. The use of topical steroids was associated with a higher risk of relapse. There was no relation between environmental factors (MC in surrounding people, going to the swimming pool, sports practice) and the number of lesions or between environmental factors and the number of recurrences. Conclusion: Atypical lesions are frequent. Bathing with siblings is associated with a higher number of MC. Topical steroid use increases the risk of relapses. AD prevalence is higher than in the general population.

show abstract

Section: Discussioncontrasting

confidence: 44%

Clinical Characteristics of Molluscum Contagiosum in Children in a Private Dermatology Practice in the Greater Paris Area, France: A Prospective Study in 661 Patients

Osio¹,

Deslandes

Saada³

et al. 2011

Dermatology

View full text Add to dashboard Cite

show abstract

“…The typical appearance of multiple discrete skin‐colored umbilicated papules is easily recognizable. Disseminated lesions may be seen in patients receiving systemic immunosuppression 1 and can localize to skin receiving topical immunosuppressive medication 2 . In patients with HIV, widespread lesions and more unusual presentations, including a cheek abscess, have been reported 3 …”

Section: Discussionmentioning

confidence: 99%

Verrucous plaques in a pemphigus vulgaris patient on immunosuppressive therapy

2012

View full text Add to dashboard Cite

“…67 The coexistence of molluscum contagiosum and verruca plana has occurred in a patient with the hyper-IgE syndrome. [69][70][71][72] Spontaneous regression often occurs within a year, although more persistent lesions are encountered. [69][70][71][72] Spontaneous regression often occurs within a year, although more persistent lesions are encountered.…”

Section: Cowpoxmentioning

confidence: 99%

Viral diseases

Weedon

2010

Weedon's Skin Pathology

View full text Add to dashboard Cite

Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus

Cited by 24 publications

References 3 publications

Clinical Characteristics of Molluscum Contagiosum in Children in a Private Dermatology Practice in the Greater Paris Area, France: A Prospective Study in 661 Patients

Clinical Characteristics of Molluscum Contagiosum in Children in a Private Dermatology Practice in the Greater Paris Area, France: A Prospective Study in 661 Patients

Verrucous plaques in a pemphigus vulgaris patient on immunosuppressive therapy

Viral diseases

Contact Info

Product

Resources

About